We are live on
!
Find out more
PA
Pinnacle Associates Portfolio holdings
AUM
$7.78B
1-Year Est. Return
45.07%
This Fund
S&P 500
This Quarter
Est. Return
+9.25%
1 Year Est. Return
+45.07%
3 Year Est. Return
+102.47%
5 Year Est. Return
+115.95%
10 Year Est. Return
+586.2%
AUM
$6.34B
AUM Growth
+$402M
(+6.8%)
Cap. Flow
-$27.6M
Cap. Flow
% of AUM
-0.43%
Top 10 Holdings %
Top 10 Hldgs %
20.1%
Holding
857
New
39
Increased
287
Reduced
431
Closed
22
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GMO US Quality ETF
QLTY
|
+$15.6M |
| 2 |
Intellia Therapeutics
NTLA
|
+$7.1M |
| 3 |
ResMed
RMD
|
+$6.82M |
| 4 |
Vanguard Morningstar Small-Cap ETF
VB
|
+$6.49M |
| 5 |
FT Vest Rising Dividend Achievers Target Income ETF
RDVI
|
+$6.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IMGN
Immunogen Inc
IMGN
|
+$30M |
| 2 |
MDC
M.D.C. Holdings, Inc.
MDC
|
+$10.4M |
| 3 |
Microsoft
MSFT
|
+$6.76M |
| 4 |
ProShares S&P MidCap 400 Dividend Aristocrats ETF
REGL
|
+$6.72M |
| 5 |
Eaton
ETN
|
+$6.72M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.92% |
| 2 | Healthcare | 11.41% |
| 3 | Financials | 10.16% |
| 4 | Industrials | 9.61% |
| 5 | Consumer Discretionary | 7.61% |
Similar funds
EHC
IMCOOI
PGFC
WRCM
SIAU
BFM
SF
MAM
Pinnacle Associates's Q1 2024 Portfolio in Review
As of Q1 2024, Pinnacle Associates held 857 positions worth $6.34B, up 6.8% from $5.94B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Pinnacle Associates's Q1 2024 filing shows 39 new, 287 increased, 431 reduced and 22 closed positions. Its largest new stake was GMO US Quality ETF: 548,868 shares worth $16.3M. The largest sale was Immunogen Inc, an estimated $30M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
- Pinnacle Associates's largest Q1 2024 buy was GMO US Quality ETF: 548,868 shares worth $16.3M.
- Pinnacle Associates added most to Vanguard Morningstar Small-Cap ETF in Q1 2024, an estimated $6.49M increase.
- Pinnacle Associates's biggest Q1 2024 reduction was Microsoft, cutting an estimated $6.76M.
- Pinnacle Associates fully exited Immunogen Inc in Q1 2024, selling an estimated $30M.
- Pinnacle Associates's ten largest holdings make up 20% of its $6.34B portfolio in Q1 2024.
- Pinnacle Associates opened 39 new positions and closed 22 in Q1 2024.
- Pinnacle Associates's portfolio value rose 6.8% quarter-over-quarter to $6.34B.
Based on Pinnacle Associates's 13F filing for Q1 2024, filed 26 Apr 2024.